110 related articles for article (PubMed ID: 7496198)
1. [2 epidemics of arsenical encephalopathy in the treatment of trypanosomiasis, Uganda, 1992-1993].
Ancelle T; Barret B; Flachet L; Moren A
Bull Soc Pathol Exot; 1994; 87(5):341-6. PubMed ID: 7496198
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.
Balasegaram M; Young H; Chappuis F; Priotto G; Raguenaud ME; Checchi F
Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):280-90. PubMed ID: 18947846
[TBL] [Abstract][Full Text] [Related]
3. Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy.
Checkley AM; Pepin J; Gibson WC; Taylor MN; Jäger HR; Mabey DC
Trans R Soc Trop Med Hyg; 2007 May; 101(5):523-6. PubMed ID: 17270227
[TBL] [Abstract][Full Text] [Related]
4. [Arsenical-induced encephalopathy during the treatment of African trypanosomiasis. Apropos of a case with a favorable outcome].
Pialoux G; Kernbaum S; Vachon F
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):555-6. PubMed ID: 3197251
[TBL] [Abstract][Full Text] [Related]
5. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P
J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469
[TBL] [Abstract][Full Text] [Related]
6. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).
Schmid C; Richer M; Bilenge CM; Josenando T; Chappuis F; Manthelot CR; Nangouma A; Doua F; Asumu PN; Simarro PP; Burri C
J Infect Dis; 2005 Jun; 191(11):1922-31. PubMed ID: 15871127
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial.
Burri C; Nkunku S; Merolle A; Smith T; Blum J; Brun R
Lancet; 2000 Apr; 355(9213):1419-25. PubMed ID: 10791526
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda].
Legros D; Fournier C; Gastellu Etchegorry M; Maiso F; Szumilin E
Bull Soc Pathol Exot; 1999 Jul; 92(3):171-2. PubMed ID: 10472443
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness.
Kuepfer I; Schmid C; Allan M; Edielu A; Haary EP; Kakembo A; Kibona S; Blum J; Burri C
PLoS Negl Trop Dis; 2012 Aug; 6(8):e1695. PubMed ID: 22970329
[TBL] [Abstract][Full Text] [Related]
11. Melarsoprol-associated multifocal inflammatory CNS illness in African trypanosomiasis.
Kumar N; Orenstein R; Uslan DZ; Berbari EF; Klein CJ; Windebank AJ
Neurology; 2006 Apr; 66(7):1120-1. PubMed ID: 16540605
[No Abstract] [Full Text] [Related]
12. Duration of symptoms and case fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in Tororo, Uganda.
Odiit M; Kansiime F; Enyaru JC
East Afr Med J; 1997 Dec; 74(12):792-5. PubMed ID: 9557424
[TBL] [Abstract][Full Text] [Related]
13. Investigations of the metabolites of the trypanocidal drug melarsoprol.
Keiser J; Ericsson O; Burri C
Clin Pharmacol Ther; 2000 May; 67(5):478-88. PubMed ID: 10824626
[TBL] [Abstract][Full Text] [Related]
14. Short-course eflornithine in Gambian trypanosomiasis: a multicentre randomized controlled trial.
Pépin J; Khonde N; Maiso F; Doua F; Jaffar S; Ngampo S; Mpia B; Mbulamberi D; Kuzoe F
Bull World Health Organ; 2000; 78(11):1284-95. PubMed ID: 11143188
[TBL] [Abstract][Full Text] [Related]
15. Production of sleeping-sickness treatment.
Pécoul B; Gastellu M
Lancet; 1999 Sep; 354(9182):955-6. PubMed ID: 10489988
[No Abstract] [Full Text] [Related]
16. Randomized controlled trial of three regimens of melarsoprol in the treatment of Trypanosoma brucei gambiense trypanosomiasis.
Pépin J; Mpia B
Trans R Soc Trop Med Hyg; 2006 May; 100(5):437-41. PubMed ID: 16483622
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness.
Pépin J; Milord F; Khonde AN; Niyonsenga T; Loko L; Mpia B; De Wals P
Trans R Soc Trop Med Hyg; 1995; 89(1):92-7. PubMed ID: 7747321
[TBL] [Abstract][Full Text] [Related]
18. [Trypanosomiasis from Trypanosoma brucei gambiense in the center of north-west Uganda. Evaluation of 5 years of control (1987-1991)].
Paquet C; Castilla J; Mbulamberi D; Beaulieu MF; Gastellu Etchegorry MG; Moren A
Bull Soc Pathol Exot; 1995; 88(1):38-41. PubMed ID: 7787452
[TBL] [Abstract][Full Text] [Related]
19. Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go.
Chappuis F
Clin Infect Dis; 2007 Dec; 45(11):1443-5. PubMed ID: 17990226
[No Abstract] [Full Text] [Related]
20. [Complications observed in the treatment of trypanosomiasis in the Congo].
Ginoux PY; Bissadidi N; Frezil JL
Med Trop (Mars); 1984; 44(4):351-5. PubMed ID: 6521632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
